NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/21/2025
Back to search
Official data from USPTO
BIORELIANCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
03/21/2025
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
01/22/2018
Registration date
01/08/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2025
Last transaction
03/21/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Darmstadt, DE
Examiner
GLASSER, CARYN
Current location
Historical data usage
Holders and representatives
Holders
Merck KGaA
Representatives
William C. Wright EPSTEIN DRANGEL LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological servicesresearch and design services in the field of process developmentvalidationqualificationmanufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services consultation services in the field of developmentmanufacturing and testing of pharmaceuticals and biopharmaceuticals; industrial analysis being scientific research services; technical and scientific consultancy in connection with filtersbioreactorschemical and pharmaceutical preparations and pharmaceutical and biopharmaceutical scientific and research projects; providing product research and development in the pharmaceutical field for purposes of process developmentvalidationqualificationmanufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceuticalbiopharmaceutical and chemical products; providing evaluation testing for pharmaceuticalbiopharmaceutical and chemical productsmedical devices featuring testing for safetytoxicitycontentidentitypurityconfiguration and functionusing chemicalin vitro or in vivo assaysanalyses and models; pre-clinical and non-clinical evaluation testing of pharmaceuticalbiopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceuticalbiopharmaceuticalchemical research and development for others
Publications
History of USPTO decisions and trademark events.
21 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/21/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/21/2025
E815
TEAS SECTION 8 & 15 RECEIVED
11/27/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/08/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/23/2018
PUBO
PUBLISHED FOR OPPOSITION
10/23/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/03/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/18/2018
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/27/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
02/21/2018
GPRA
PRIORITY ACTION E-MAILED
02/21/2018
CPRA
PRIORITY ACTION WRITTEN
02/21/2018
DOCK
ASSIGNED TO EXAMINER
02/13/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/01/2018
NWAP
NEW APPLICATION ENTERED
01/25/2018
Continuous trademark protection
Get notified about every new filing that threatens BIORELIANCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.